Kriya Therapeutics
Kara Shumansky is an accomplished scientist with extensive experience in immunology and bioanalytical assay development. Currently serving as Scientist III at Kriya Therapeutics, Inc., Kara previously held roles at FUJIFILM Diosynth Biotechnologies and BioAgilytix, focusing on drug potency assays and compliance with regulatory standards. Notable achievements include the isolation of primary human cell types and the optimization of analytical assays at Novabiosis, alongside hands-on experience in gene therapy product analysis at Pfizer. Kara's educational background includes a Master's Degree in Molecular Genetics and Microbiology from Duke University and a Bachelor’s Degree in Biology from McGill University.
This person is not in any teams
This person is not in any offices
Kriya Therapeutics
2 followers
Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs.